Morco (Fluticasone Furoate)

Fluticasone furoate, the active ingredient in Morco, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis, seasonal allergic rhinitis and perennial allergic rhinitis in patients who require a nasal corticosteroid. GNH USA supplies Morco as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Fluticasone furoate is a nasal corticosteroid that reduces inflammation in the nasal passages.

Allergic rhinitis: alleviates congestion, sneezing, itching and rhinorrhea. Seasonal allergic rhinitis: provides symptom relief during pollen or mold seasons. Perennial allergic rhinitis: controls year‑round nasal symptoms caused by indoor allergens.

Fluticasone furoate may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Headache. - Epistaxis (nosebleed). - Throat irritation or cough. - Altered taste perception. - Dryness of nasal passages.

Serious or Rare Side Effects: - Nasal septal perforation. - Severe allergic reaction (anaphylaxis). - Vision changes or cataract formation. - Adrenal suppression with prolonged high‑dose use. - Opportunistic fungal infection of the nasal cavity. - Profound or persistent nosebleeds.

Before using Morco, consider the following precautions.

Pregnancy: consult a healthcare professional; safety data are limited. Breastfeeding: discuss potential risks with a physician. Pediatric use: use only as prescribed; safety not established for children under two years. Concurrent nasal surgery: avoid use at least two weeks before and after the procedure. Systemic corticosteroid therapy: monitor for additive immunosuppressive effects. Store at room temperature: keep in the original container, protect from moisture and heat.

Fluticasone furoate may interact with other medicines; review the following.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole) may increase systemic exposure. - Systemic immunosuppressants may heighten risk of infection. - Live vaccines may have reduced efficacy.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., itraconazole) may modestly raise drug levels. - Ritonavir or other protease inhibitors may increase exposure. - Concurrent use of other nasal sprays may increase local irritation.